Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pylorin vs Quintuple Therapy for H. pylori Eradication
NCT03837210Phase 3Completed
- Sponsor
- Hamdard University
- Start
- Jan 2017
- Primary completion
- Jan 2019
01
Overview
Phase 3, randomised trial in Helicobacter pylori infection (2 arms), sponsored by Hamdard University. Primary endpoint: Eradication of H. Pylori at 4 weeks. Started Jan 2017; status: completed.
02
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03837210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03837210.